Citation tools
"A Phase II, Open-Label Study to Assess Safety and Management Change Using 68Ga-THP PSMA PET/CT in Patients with High-Risk Primary Prostate Cancer or Biochemical Recurrence After Radical Treatment: The PRONOUNCED Study." Journal of Nuclear Medicine
62.12
(2021):
1727-1734.
Web. 18 April. 2024.